Xenetic Biosciences Inc (XBIO) - Total Liabilities

Latest as of September 2025: $1.11 Million USD

Based on the latest financial reports, Xenetic Biosciences Inc (XBIO) has total liabilities worth $1.11 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Xenetic Biosciences Inc (XBIO) net asset momentum to track the company's year-over-year net asset growth rate.

Xenetic Biosciences Inc - Total Liabilities Trend (2011–2024)

This chart illustrates how Xenetic Biosciences Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Xenetic Biosciences Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Xenetic Biosciences Inc Competitors by Total Liabilities

The table below lists competitors of Xenetic Biosciences Inc ranked by their total liabilities.

Company	Country	Total Liabilities
ARK Resources Bhd KLSE:7007	Malaysia	RM59.30 Million
Northern Shield Resources Inc. V:NRN	Canada	CA$451.66K
Austchina Holdings Ltd AU:AUH	Australia	AU$1.64 Million
Solteq PLC HE:SOLTEQ	Finland	€35.22 Million
ESE Entertainment Inc V:ESE	Canada	CA$9.18 Million
Union Pioneer Public Company Limited BK:UPF	Thailand	฿144.96 Million
Teamo Productions HQ Limited NSE:TPHQ	India	Rs152.05 Million
Nandani Creation Limited NSE:JAIPURKURT	India	Rs623.08 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Xenetic Biosciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Xenetic Biosciences Inc market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Xenetic Biosciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Xenetic Biosciences Inc (2011–2024)

The table below shows the annual total liabilities of Xenetic Biosciences Inc from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	$894.26K	+10.46%
2023-12-31	$809.59K	-24.56%
2022-12-31	$1.07 Million	-24.48%
2021-12-31	$1.42 Million	+47.42%
2020-12-31	$963.97K	-77.76%
2019-12-31	$4.33 Million	-4.09%
2018-12-31	$4.52 Million	-7.07%
2017-12-31	$4.86 Million	+1.20%
2016-12-31	$4.80 Million	-53.35%
2015-12-31	$10.30 Million	+76.50%
2014-12-31	$5.84 Million	-14.79%
2013-12-31	$6.85 Million	+49.11%
2012-12-31	$4.59 Million	+1980.58%
2011-12-31	$220.74K	--

About Xenetic Biosciences Inc

NASDAQ:XBIO USA Biotechnology

Market Cap

$5.81 Million

Market Cap Rank

#28548 Global

#5771 in USA

Share Price

$2.54

Change (1 day)

-0.59%

52-Week Range

$2.02 - $10.36

All Time High

$3642.84